Zephyrnet Logo

Tag: Cardiovascular

Top News

21 Class III Devices Exempted for Clinical Trial: Faster Market Access for Surgical Equipment in Cardio, Neuro, Ortho, Aesthetic and Dental Applications

NMPA issued the “Clinical Pathway Recommendations for Certain Categories of Medical Devices” today on March 18, 2024. The document suggests manufacturers how to choose...

Nanoparticles turbocharge turmeric’s curcumin for enhanced health benefits

A review article published in the journal Antioxidants provides a detailed overview of nanoparticle-based strategies to improve the bioavailability and bioactivity of curcumin. Study: Enhancing...

Federated learning on AWS using FedML, Amazon EKS, and Amazon SageMaker | Amazon Web Services

This post is co-written with Chaoyang He, Al Nevarez and Salman Avestimehr from FedML. Many organizations are...

CCC Responds to RFI on NIH’s Strategic Plan for Data Science 2023-2028 » CCC Blog

Today, CCC submitted a response to a Request for Information released by the National Institutes of Health (NIH) on their Strategic Plan for Data...

Boosting curcumin’s absorption and effectiveness for disease prevention and therapy

In a recent review published in the journal Antioxidants, researchers explored the potential of nano-formulations to boost the bioavailability and bioactivity of curcumin and...

Gene Silencing Reduces Cholesterol Levels in Mice without the Need for Gene Edits

Gene Silencing Reduces Cholesterol Levels in Mice without the Need for Gene Edits High cholesterol levels are a major risk factor for cardiovascular diseases, including...

Gene Silencing Reduces Cholesterol Levels in Mice without the Need for Gene Editing

Gene Silencing Reduces Cholesterol Levels in Mice without the Need for Gene Editing High cholesterol levels are a major risk factor for cardiovascular diseases, including...

The Weekly Notable Startup Funding Report: 2/26/24

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity...

Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report

Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the...

Latest Intelligence

spot_img
spot_img